Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in miceXAIOPING LIANG; FU, Tong-Ming; HONG XIE et al.Vaccine. 2002, Vol 20, Num 27-28, pp 3413-3421, issn 0264-410X, 9 p.Article

Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pollnef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 VaccineQURESHI, Huma; MA, Zhong-Min; SHIVER, John W et al.Journal of virology. 2012, Vol 86, Num 4, pp 2239-2250, issn 0022-538X, 12 p.Article

Evaluation of cellular immune responses in subjects chronically infected with HIV type 1FU, Tong-Ming; DUBEY, Sheri A; GOEPFERT, Paul A et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 67-76, issn 0889-2229, 10 p.Article

HIV type 1 vaccines for worldwide use : Predicting in-clade and cross-clade breadth of immune responsesFINNEFROCK, Adam C; XIAOMEI LIU; OPALKA, David W et al.AIDS research and human retroviruses. 2007, Vol 23, Num 10, pp 1283-1292, issn 0889-2229, 10 p.Article

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239WILSON, Nancy A; REED, Jason; SOMA, Taeko et al.Journal of virology. 2006, Vol 80, Num 12, pp 5875-5885, issn 0022-538X, 11 p.Article

Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursorBIANCHI, Elisabetta; XIAOPING LIANG; MANGER, Walter et al.Journal of virology. 2005, Vol 79, Num 12, pp 7380-7388, issn 0022-538X, 9 p.Article

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trialsMAST, T. Christopher; KIERSTEAD, Lisa; WOLFE, Nathan D et al.Vaccine. 2010, Vol 28, Num 4, pp 950-957, issn 0264-410X, 8 p.Article

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysFU, Tong-Ming; GRIMM, Karen M; CITRON, Michael P et al.Vaccine. 2009, Vol 27, Num 9, pp 1440-1447, issn 0264-410X, 8 p.Article

Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed mamu-A*01-positive rhesus macaquesMCDERMOTT, Adrian B; O'CONNOR, David H; RIEK, Cara et al.Journal of virology. 2005, Vol 79, Num 24, pp 15556-15566, issn 0022-538X, 11 p.Article

Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccinesEVANS, Robert K; ZHU, De-Min; ISOPI, Lynne A et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 7, pp 1924-1939, issn 0022-3549, 16 p.Article

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunitySHIVER, John W; FU, Tong-Ming; LINGYI HUANG et al.Nature (London). 2002, Vol 415, Num 6869, pp 331-335, issn 0028-0836Article

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus ChallengeCASIMIRO, Danilo R; COX, Kara; TOBERY, Timothy W et al.Journal of virology. 2010, Vol 84, Num 6, pp 2996-3003, issn 0022-538X, 8 p.Article

Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humansBETT, Andrew J; DUBEY, Sheri A; MESCHINO, Steve et al.Vaccine. 2010, Vol 28, Num 50, pp 7881-7889, issn 0264-410X, 9 p.Article

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy AdultsPRIDDY, Frances H; BROWN, Deborah; BROWN, Stephen J et al.Clinical infectious diseases. 2008, Vol 46, Num 11, pp 1769-1781, issn 1058-4838, 13 p.Article

Influence of peak viral load on the extent of CD4⁺ T-cell depletion in simian hiv infectionDAVENPORT, Miles P; LEI ZHANG; SHIVER, John W et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 41, Num 3, pp 259-265, issn 1525-4135, 7 p.Article

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing GagCASIMIRO, Danilo R; FUBAO WANG; BAGCHI, Ansu et al.Journal of virology. 2005, Vol 79, Num 24, pp 15547-15555, issn 0022-538X, 9 p.Article

Primary Human Immunodeficiency Virus Type 1 (HIV-1) Infection during HIV-1 Gag VaccinationBALAMURUGAN, Arumugam; LEWIS, Martha J; YANG, Otto O et al.Journal of virology. 2008, Vol 82, Num 6, pp 2784-2791, issn 0022-538X, 8 p.Article

Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primatesSIMON, Adam J; CASIMIRO, Danilo R; FINNEFROCK, Adam C et al.Vaccine. 2008, Vol 26, Num 40, pp 5202-5209, issn 0264-410X, 8 p.Conference Paper

Enhanced rates and magnitude of immune responses detected against an HIV vaccine : Effect of using an optimized process for isolating PBMCKIERSTEAD, Lisa S; DUBEY, Sheri; SYKES, Kara J et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 86-92, issn 0889-2229, 7 p.Article

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaquesHAZUDA, Daria J; YOUNG, Steven D; DORNADULA, Geethanjali et al.Science (Washington, D.C.). 2004, Vol 305, Num 5683, pp 528-532, issn 0036-8075, 5 p.Article

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysJIANG FAN; XIAOPING LIANG; GARSKY, Victor M et al.Vaccine. 2004, Vol 22, Num 23-24, pp 2993-3003, issn 0264-410X, 11 p.Article

Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost RegimensASMUTH, David M; BROWN, Elizabeth L; CASIMIRO, Danilo R et al.The Journal of infectious diseases. 2010, Vol 201, Num 1, pp 132-141, issn 0022-1899, 10 p.Article

DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response ProfilesCOX, Kara S; CLAIR, James H; PROKOP, Michael T et al.Journal of virology. 2008, Vol 82, Num 16, pp 8161-8171, issn 0022-538X, 11 p.Article

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assayDUBEY, Sheri; CLAIR, James; LAN ZHU et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 1, pp 20-27, issn 1525-4135, 8 p.Article

A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV type 1 gag vaccinated human subjectsTOBERY, Timothy W; DUBEY, Sheri A; FU, Tong-Ming et al.AIDS research and human retroviruses. 2006, Vol 22, Num 11, pp 1081-1090, issn 0889-2229, 10 p.Article